Clinical and Molecular Effect of the Anti–IL‐18 Antibody Aletekitug in Adults With Atopic Dermatitis
At Week 12, aletekitug was associated with a −68.3% percentage change from baseline in EASI score. Aletekitug improved the transcriptional profile of lesional skin towards that of non‐lesional skin at Week 4 and Week 12. Aletekitug was well‐tolerated; no serious adverse event or death occurred, and no patient withdrew due to an adverse event.
Joanne Ellis +32 more
wiley +1 more source
Angiotensin‐II type 1 receptor‐mediated Janus kinase 2 activation induces liver fibrosis
M. Granzow +21 more
semanticscholar +1 more source
ABSTRACT Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare and potentially life‐threatening systemic, inflammatory disease with multi‐organ manifestations, variable presentation and complex pathology. Multiple interconnected immunological pathways are implicated in EGPA pathology, including a type‐2 immune response driving predominantly ...
Harold Wilson‐Morkeh +7 more
wiley +1 more source
MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2.
Siliang Wang, Xiaodong Chen, M. Tang
semanticscholar +1 more source
ABSTRACT Background Lichen sclerosus is a chronic, inflammatory, scarring disease of the skin that manifests mostly in the genital region. Objective We studied the histomorphological characteristics, grade, and pattern of inflammation in male pediatric patients with lichen sclerosus.
Valerie Flammang +10 more
wiley +1 more source
Statement of Retraction: Homeodomain-containing gene 10 contributed to breast cancer malignant behaviors by activating Interleukin-6/Janus kinase 2/Signal transducer and activator of transcription 3 pathway. [PDF]
europepmc +1 more source
Limited efficacy of BMS-911543 in a murine model of Janus kinase 2 V617F myeloproliferative neoplasm [PDF]
Anthony D. Pomicter +7 more
openalex +1 more source
When, which and how to switch: Navigating JAK inhibitors in myelofibrosis
Navigating choice of JAK inhibitor (JAKi) therapy for patients with myelofibrosis who are JAKi‐naïve and for those who have previously been treated with a JAKi.
Jennifer O'Sullivan +2 more
wiley +1 more source
Prediction of the structure of human Janus kinase 2 (JAK2) comprising JAK homology domains 1 through 7 [PDF]
Fabrizio Giordanetto, Romano T. Kroemer
openalex +1 more source

